Aldaas, Omar Mahmoud
Malladi, Chaitanya
Han, Frederick T.
Hoffmayer, Kurt S.
Krummen, David
Ho, Gordon
Raissi, Farshad
Birgersdotter-Green, Ulrika
Feld, Gregory K.
Hsu, Jonathan C. http://orcid.org/0000-0002-1523-573X
Article History
Received: 7 September 2023
Accepted: 2 October 2023
First Online: 19 October 2023
Declarations
:
: No IRB was needed as this was a meta-analysis of data that has already been published.
: Was not necessary as this was a meta-analysis of data that has already been published.
: Dr. Hsu reports receiving honoraria from Medtronic, Abbott, Boston Scientific, Biotronik, Janssen Pharmaceuticals, Bristol-Myers Squibb, Pfizer, Sanofi, Zoll Medical, Hillrom, iRhythm, Acutus Medical, and Biosense-Webster; equity interest in Vektor Medical; and research grants from Biotronik and Biosense-Webster. Dr. Ho reports receiving a research grant from Abbott, equity in Vektor Medical, and fellowship support from Medtronic, Abbott, Boston Scientific, and Biotronik. Dr. Feld reports receiving fellowship training program stipends (as CCEP fellowship training program director) from Medtronic, Biotronik, Biosense Webster, and Abbott Medical; has equity interest in Vektor Medical; is co-founder and co-owner of Perminova; and is a consultant to Acutus Medical. Dr Han receives research support from Abbott and honoraria from Abbott.